Repare Therapeutics (NASDAQ:RPTX) and Hutchison China MediTech (NASDAQ:HCM) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.
Insider and Institutional Ownership
64.8% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 33.5% of Hutchison China MediTech shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Repare Therapeutics and Hutchison China MediTech's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Repare Therapeutics | N/A | N/A | N/A |
Hutchison China MediTech | N/A | N/A | N/A |
Earnings & Valuation
This table compares Repare Therapeutics and Hutchison China MediTech's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Repare Therapeutics | N/A | N/A | N/A | N/A | N/A |
Hutchison China MediTech | $204.89 million | 20.81 | $-106,020,000.00 | ($0.80) | -36.63 |
Repare Therapeutics has higher earnings, but lower revenue than Hutchison China MediTech.
Analyst Recommendations
This is a summary of current ratings and target prices for Repare Therapeutics and Hutchison China MediTech, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Repare Therapeutics | 0 | 1 | 5 | 1 | 3.00 |
Hutchison China MediTech | 0 | 0 | 2 | 0 | 3.00 |
Repare Therapeutics presently has a consensus price target of $39.40, suggesting a potential upside of 21.38%. Hutchison China MediTech has a consensus price target of $40.00, suggesting a potential upside of 36.52%. Given Hutchison China MediTech's higher possible upside, analysts clearly believe Hutchison China MediTech is more favorable than Repare Therapeutics.
Summary
Repare Therapeutics beats Hutchison China MediTech on 3 of the 5 factors compared between the two stocks.